Advanced glycation end products (AGEs) increase reactive oxygen species formation and impair antioxidant systems that activate NF-κB signaling pathway which enhanced the production of the cytokine interleukin-6 (IL-6) involved not only in inflammation and infection responses but also in the regulation of metabolic, regenerative, and neural processes [47]. The gene discussed is IL6; the disease is infection.